Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Tongling Jieya Biologic Technology
301108
5
WUXI JINGHAI
836547
(Q3)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets | ||||||||||
Money funds | -1.99%1.48B | -3.83%1.7B | -5.43%1.38B | -1.21%1.39B | 1.42%1.51B | 6.16%1.76B | 0.83%1.46B | -1.99%1.41B | -1.44%1.49B | 3.51%1.66B |
Notes receivable and accounts receivable | 9.60%77.12M | 6.19%71.97M | -39.56%56.98M | 3.71%74.28M | 23.21%70.36M | 54.32%67.77M | 39.80%94.27M | -23.60%71.62M | -39.60%57.1M | -37.95%43.92M |
-Notes receivable | 33.11%5.16M | -77.88%5.46M | 92.57%6.94M | 108.35%7.72M | -58.29%3.88M | 146.56%24.69M | 35.08%3.6M | 43.95%3.7M | 517.88%9.3M | 565.26%10.01M |
-Accounts receivable | 8.23%71.96M | 54.38%66.51M | -44.81%50.04M | -1.99%66.57M | 39.07%66.48M | 27.07%43.08M | 39.99%90.67M | -25.50%67.92M | -48.62%47.8M | -51.06%33.9M |
Other receivables (including interest and dividends) | -33.79%11.4M | -35.03%13.5M | -18.30%14.57M | -21.69%17.25M | -7.81%17.22M | 25.35%20.78M | 2.52%17.84M | 21.09%22.03M | -5.95%18.68M | -5.22%16.58M |
-Dividend receivable | ---- | ---- | --0 | ---- | ---- | --4.9M | ---- | ---- | ---- | ---- |
-Other receivable | ---- | ---- | ---- | -21.69%17.25M | ---- | -4.21%15.88M | ---- | 21.09%22.03M | ---- | -5.22%16.58M |
Contractual assets | 128.53%124.91M | 147.67%99.76M | 40.98%114.66M | -14.83%72.04M | 36.61%54.66M | 65.95%40.28M | 19.12%81.33M | 121.93%84.58M | 14.23%40.01M | -16.47%24.27M |
Advance payment | 16.41%48.23M | 48.34%53.1M | -13.29%50.64M | 3.71%41.81M | -7.87%41.43M | -33.37%35.79M | -12.65%58.4M | -33.45%40.31M | 4.21%44.97M | 42.14%53.73M |
Inventories | -25.40%442.19M | -37.96%407.06M | -10.80%467.66M | -33.22%469.79M | -24.03%592.72M | -24.48%656.12M | -34.77%524.28M | -26.40%703.49M | -33.18%780.17M | -32.85%868.77M |
Other current assets | 30.19%10.46M | --6.98M | -21.16%6.1M | -51.10%8.52M | -21.74%8.04M | ---- | 1,102,795.13%7.74M | 5,122.38%17.43M | 926.48%10.27M | 177,032.58%1.24M |
Total current assets | -4.36%2.19B | -9.13%2.35B | -6.80%2.09B | -11.63%2.07B | -5.97%2.29B | -3.20%2.58B | -9.24%2.24B | -9.84%2.35B | -15.03%2.44B | -12.58%2.67B |
Non Current assets | ||||||||||
Investment real estate | -3.19%69.82M | -3.17%70.4M | -3.14%70.97M | -3.12%71.55M | -3.09%72.12M | -3.07%72.7M | -3.05%73.27M | -3.02%73.85M | -3.00%74.43M | -2.98%75M |
Long-term equity investment | 4.08%295.64M | 4.38%294.31M | 4.37%284.24M | 5.83%289.65M | 18.15%284.05M | 19.90%281.96M | 17.42%272.34M | 20.65%273.7M | 7.53%240.41M | 6.97%235.17M |
Fixed assets | ---- | ---- | ---- | -11.33%78.4M | ---- | -12.79%82.24M | ---- | 1.15%88.42M | ---- | 4.58%94.3M |
Fixed assets liquidation | ---- | ---- | ---- | -26.13%201.72 | ---- | ---- | ---- | --273.09 | ---- | ---- |
Constru in process | ---- | ---- | ---- | --8.63M | ---- | --3.9M | ---- | ---- | ---- | ---- |
Intangible assets | 12.93%18.55M | -11.62%15.18M | 84.70%15.6M | 86.60%16.38M | 151.57%16.43M | 146.04%17.18M | 32.65%8.44M | 29.73%8.78M | -8.86%6.53M | 6.97%6.98M |
Development expenditure | ---- | ---- | --0 | ---- | ---- | ---- | 94.58%8.97M | 186.33%8.38M | 431.65%9.91M | --8.19M |
Long deferred expense | 102.26%960.99K | --1.07M | --339.37K | --407.24K | --475.12K | ---- | ---- | ---- | ---- | ---- |
Deferred tax assets | 1.39%9.83M | 1.95%9.83M | 116.69%10.31M | 115.08%10.3M | 109.71%9.69M | 108.57%9.64M | 78.29%4.76M | 60.93%4.79M | 58.64%4.62M | 85.32%4.62M |
Usufruct assets | -4.81%39.36M | -4.26%40.38M | 1.59%41.4M | 1.21%42.41M | -4.60%41.35M | 3.20%42.18M | -3.09%40.75M | -3.06%41.9M | -2.89%43.34M | -6.61%40.87M |
Other non current assets | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Total non current assets | 6.01%536.94M | 4.38%532.13M | 3.29%510.24M | 3.58%517.72M | 7.55%506.51M | 9.60%509.79M | 9.12%494M | 11.99%499.82M | 5.72%470.94M | 5.41%465.13M |
Total assets | -2.49%2.73B | -6.90%2.88B | -4.98%2.6B | -8.96%2.59B | -3.78%2.8B | -1.30%3.09B | -6.39%2.73B | -6.64%2.85B | -12.25%2.91B | -10.31%3.13B |
Liabilities | ||||||||||
Current liabilities | ||||||||||
Notes payable and accounts payable | 62.06%356.01M | 18.24%395.95M | 23.92%281.89M | -27.45%199.41M | -3.18%219.68M | 24.92%334.87M | 0.47%227.48M | 23.07%274.87M | -13.35%226.9M | -6.83%268.07M |
-Notes payable | -87.18%2.44M | -96.41%377.5K | -83.79%3.9M | -31.40%15.71M | 153.58%19.01M | -6.66%10.51M | 499.23%24.04M | 342.16%22.9M | 35.01%7.5M | 24.71%11.26M |
-Accounts payable | 76.20%353.57M | 21.95%395.58M | 36.64%277.99M | -27.10%183.7M | -8.54%200.67M | 26.30%324.36M | -8.53%203.44M | 15.50%251.97M | -14.40%219.4M | -7.86%256.82M |
Contract liabilities | -31.23%500.48M | -35.90%599.07M | -36.34%453.9M | -35.53%560.85M | -30.12%727.79M | -25.99%934.63M | -36.89%713.05M | -31.82%869.95M | -33.46%1.04B | -27.53%1.26B |
Advance receipts | 14.11%726.47K | -32.02%862.99K | 64.61%1.03M | 154.46%1.63M | -23.09%636.63K | -10.76%1.27M | -60.07%624.53K | -26.18%639.57K | 119.33%827.71K | 133.44%1.42M |
Salaries payable | 41.01%69.09M | -2.23%50.44M | 20.23%49.33M | 20.45%48.83M | 22.51%49M | 23.90%51.59M | 2.08%41.03M | 0.23%40.54M | 0.47%39.99M | 6.52%41.64M |
Taxs payable | -75.91%2.15M | 31.23%34.34M | -7.89%10.15M | -15.01%7.81M | -2.13%8.91M | 16.67%26.17M | -17.31%11.02M | -23.19%9.19M | 6.48%9.11M | -10.88%22.43M |
Other payable (including interest and dividends) | -31.03%34.19M | -40.65%35.52M | -62.19%32.26M | -47.85%35.55M | 92.54%49.57M | 54.81%59.85M | 147.75%85.32M | -13.34%68.16M | -26.43%25.75M | -33.17%38.66M |
-Interest payable | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Dividend payable | ---- | -79.69%212.64K | -79.69%212.64K | -99.53%212.64K | 36.91%951.16K | -21.22%1.05M | -21.22%1.05M | -0.03%45.32M | 1.54%694.75K | 34.36%1.33M |
-Other payable | ---- | ---- | --32.05M | 54.70%35.33M | ---- | 57.51%58.8M | ---- | -31.46%22.84M | ---- | -34.35%37.33M |
Non current liabilities due within one year | 31.38%3.77M | 31.38%3.73M | 45.92%3.68M | 19.20%3.64M | -25.68%2.87M | 77.85%2.84M | 13.09%2.52M | 6.71%3.05M | -2.53%3.86M | -35.77%1.6M |
Other current liabilities | -80.39%212.08K | -40.98%667.76K | 16.27%1.03M | -33.52%926.75K | -26.60%1.08M | 17.65%1.13M | 10.43%885.95K | -5.43%1.39M | -54.55%1.47M | -73.53%961.6K |
Total current liabilities | -8.77%966.63M | -20.66%1.12B | -22.98%833.27M | -32.27%858.64M | -21.48%1.06B | -13.76%1.41B | -25.33%1.08B | -22.49%1.27B | -29.65%1.35B | -24.15%1.64B |
Current liabilities | ||||||||||
Long term salaries pay | -5.22%1.61M | -5.22%1.61M | -2.87%1.7M | -1.20%1.7M | -1.20%1.7M | -1.20%1.7M | -0.12%1.75M | -1.82%1.72M | -3.39%1.72M | -1.82%1.72M |
Long term deferred income | -3.50%27.65M | -2.99%28.09M | 265.15%30.5M | 241.95%30.78M | 242.09%28.65M | 228.95%28.96M | 3.89%8.35M | 19.50%9M | 5.72%8.38M | 29.57%8.8M |
Lease liabilities | -5.11%44.86M | -4.61%45.24M | -0.35%47.47M | 0.07%47.82M | -1.36%47.28M | 0.42%47.43M | -1.60%47.64M | -1.58%47.79M | -1.55%47.93M | -3.23%47.23M |
Total non current liabilities | -4.52%74.12M | -4.02%74.94M | 38.18%79.78M | 37.24%80.29M | 33.79%77.63M | 35.21%78.08M | -0.80%57.74M | 1.16%58.5M | -0.62%58.02M | 0.70%57.75M |
Total liabilities | -8.48%1.04B | -19.79%1.2B | -19.88%913.06M | -29.21%938.93M | -19.20%1.14B | -12.09%1.49B | -24.38%1.14B | -21.68%1.33B | -28.79%1.41B | -23.51%1.7B |
Shareholders equity | ||||||||||
Paid-in capital | -0.06%371.67M | -0.06%371.67M | -0.06%371.67M | -0.06%371.67M | 0.00%371.9M | 0.00%371.9M | 0.00%371.9M | -0.05%371.9M | -0.05%371.9M | -0.05%371.9M |
Capital reserve funds | -4.97%49.37M | -7.53%49.37M | -3.71%49.05M | -0.70%49.76M | 6.95%51.96M | 12.46%53.39M | 15.93%50.94M | 16.22%50.11M | 17.81%48.58M | 21.92%47.47M |
Surplus reserve funds | 9.06%147.27M | 9.06%147.27M | 15.37%135.03M | 15.37%135.03M | 15.36%135.03M | 15.37%135.03M | 17.40%117.04M | 17.40%117.04M | 17.40%117.05M | 17.40%117.04M |
Retained profit | -0.18%1.11B | 4.60%1.1B | 5.73%1.13B | 10.41%1.1B | 13.06%1.11B | 13.65%1.05B | 15.65%1.07B | 14.73%993.66M | 14.63%979.52M | 15.05%926.06M |
Less:Treasury stock | ---- | -87.73%1.41M | -89.24%1.41M | -89.24%1.41M | -81.09%2.54M | -51.34%11.47M | -48.15%13.07M | -49.82%13.07M | -49.80%13.42M | -37.32%23.57M |
Other composite income | 0.00%16.8K | 0.00%16.8K | 0.00%16.8K | 0.00%16.8K | 0.00%16.8K | 0.00%16.8K | 0.00%16.8K | 0.00%16.8K | 0.00%16.8K | 0.00%16.8K |
Specific reserves | --20.01K | 0.00%20.01K | --20.01K | ---- | ---- | --20.01K | ---- | ---- | ---- | ---- |
Shareholders equity without minority interests | 0.60%1.67B | 4.15%1.67B | 5.56%1.68B | 8.72%1.65B | 10.65%1.66B | 11.29%1.6B | 12.80%1.59B | 12.15%1.52B | 12.14%1.5B | 12.58%1.44B |
Minority interests | --16.76M | 871.26%16.55M | --1.94M | ---- | ---- | --1.7M | ---- | ---- | ---- | ---- |
Total shareholder equity | 1.61%1.69B | 5.07%1.68B | 5.69%1.68B | 8.72%1.65B | 10.65%1.66B | 11.41%1.6B | 12.80%1.59B | 12.15%1.52B | 12.14%1.5B | 12.58%1.44B |
Total liabilityies and equity | -2.49%2.73B | -6.90%2.88B | -4.98%2.6B | -8.96%2.59B | -3.78%2.8B | -1.30%3.09B | -6.39%2.73B | -6.64%2.85B | -12.25%2.91B | -10.31%3.13B |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion |
Auditor | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) | -- | -- | -- | Shinaga Zhonghe Certified Public Accountants Co., Ltd. (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.